JP2002514404A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514404A5
JP2002514404A5 JP2000548371A JP2000548371A JP2002514404A5 JP 2002514404 A5 JP2002514404 A5 JP 2002514404A5 JP 2000548371 A JP2000548371 A JP 2000548371A JP 2000548371 A JP2000548371 A JP 2000548371A JP 2002514404 A5 JP2002514404 A5 JP 2002514404A5
Authority
JP
Japan
Prior art keywords
polypeptide
composition
conjugated
patient
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000548371A
Other languages
English (en)
Japanese (ja)
Other versions
JP4542705B2 (ja
JP2002514404A (ja
Filing date
Publication date
Priority claimed from AUPP3450A external-priority patent/AUPP345098A0/en
Application filed filed Critical
Publication of JP2002514404A publication Critical patent/JP2002514404A/ja
Publication of JP2002514404A5 publication Critical patent/JP2002514404A5/ja
Application granted granted Critical
Publication of JP4542705B2 publication Critical patent/JP4542705B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000548371A 1998-05-11 1999-05-07 オーストラリア・ブラウン・スネーク，プソイドナジャ・テキスティリス・テキスティリスからのプラスミンインヒビター Expired - Fee Related JP4542705B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP3450A AUPP345098A0 (en) 1998-05-11 1998-05-11 Novel anti-fibrinolytic agents
AU3450 1998-05-11
PCT/AU1999/000343 WO1999058569A1 (en) 1998-05-11 1999-05-07 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS)

Publications (3)

Publication Number Publication Date
JP2002514404A JP2002514404A (ja) 2002-05-21
JP2002514404A5 true JP2002514404A5 (enExample) 2006-07-13
JP4542705B2 JP4542705B2 (ja) 2010-09-15

Family

ID=3807704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000548371A Expired - Fee Related JP4542705B2 (ja) 1998-05-11 1999-05-07 オーストラリア・ブラウン・スネーク，プソイドナジャ・テキスティリス・テキスティリスからのプラスミンインヒビター

Country Status (11)

Country Link
US (1) US7070969B1 (enExample)
EP (1) EP1078003B1 (enExample)
JP (1) JP4542705B2 (enExample)
AT (1) ATE440108T1 (enExample)
AU (1) AUPP345098A0 (enExample)
CA (1) CA2328431C (enExample)
DE (1) DE69941292D1 (enExample)
DK (1) DK1078003T3 (enExample)
ES (1) ES2332249T3 (enExample)
NZ (1) NZ508770A (enExample)
WO (1) WO1999058569A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP345098A0 (en) * 1998-05-11 1998-06-04 National Institute Of Biological Standards And Control, United Kingdom Novel anti-fibrinolytic agents
US6506365B1 (en) * 2000-09-25 2003-01-14 Baxter Aktiengesellschaft Fibrin/fibrinogen binding conjugate
US7745192B2 (en) 2002-04-03 2010-06-29 Venomics Pty Limited Prothrombin activating protein
DK1976985T3 (da) 2005-12-29 2013-10-21 Univ California Fremgangsmåder og præparater relateret til mutant Kunitz-domæne I af TFPI-2
EP2154152A1 (en) * 2008-08-08 2010-02-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of Conkunitzin-S1 for the modulation of glucose-induced insulin secretion
WO2010055950A1 (ja) * 2008-11-17 2010-05-20 財団法人ヒューマンサイエンス振興財団 癌間質の構成因子に対して特異的結合能を有する物質と抗腫瘍性化合物との複合体による新規の癌ターゲティング治療
CN102850451B (zh) * 2011-06-29 2014-05-07 辽宁诺康生物制药有限责任公司 具有抑制纤溶酶活性的重组textilinin-1及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342830A (en) * 1990-11-16 1994-08-30 Cor Therapeutics, Inc. Antithrombosis agents
EP0585504A1 (en) * 1992-09-04 1994-03-09 Pentapharm A.G. Phospholipid dependant prothrombin activator and its use in lupus anticoagulant testing
AUPP076797A0 (en) * 1997-12-05 1998-01-08 Active (Pla) R&D Pty Ltd Phospholipase inhibitor
AUPP345098A0 (en) * 1998-05-11 1998-06-04 National Institute Of Biological Standards And Control, United Kingdom Novel anti-fibrinolytic agents

Similar Documents

Publication Publication Date Title
WO2005081711A3 (en) Monomethylvaline compounds capable of conjugation to ligands
CA2267456A1 (en) Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
EP1198256A4 (en) Peptide-lipid conjugates, liposomes and liposomal drug delivery
WO2001068138A3 (en) Intradermal-penetration agents for topical local anesthetic administration
JP2001522783A5 (enExample)
JP2003505345A5 (enExample)
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
FR2791678B1 (fr) Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
PT1214077E (pt) Libertacao local de estradiol 17-beta para melhorar a funcao vascular do endotelio na sequencia de feridas vasculares
BR9815562A (pt) Processo de preparação de nanocápsulas, suspenção coloidal de nanocápsulas e composição terapêutica
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
AU2001264044A1 (en) 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
JP2002542248A5 (enExample)
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
EG23994A (en) Pharmaceutical compositions for oral and topical administration
WO2001060412A3 (en) Modification of biopolymers for improved drug delivery
JP2001513504A5 (enExample)
JP2004500325A5 (enExample)
AR016427A1 (es) CONJUGADOS uTILES PARA EL TRATAMIENTO DE CÁNCER DE PRoSTATA, Y UNA COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE.
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
EP0931545A3 (en) Droloxifene pharmaceutical compositions
WO2003037272A3 (en) Thymosin alpha 1 peptide/polymer conjugates
CA2337667A1 (en) Dextran-leptin conjugates, pharmaceutical compositions and related methods